Skip to content

Elecsys Ferritin 4491785160Recalls & reported problems

Roche Diagnostics GmbH · Class 2

All models of Elecsys Ferritin (3)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 04015630938957), received between Jun 22, 2023 and Sep 18, 2024 — classified as 3 malfunctions.

The most frequently reported specific device problem is “Low Test Results” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 1 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 1 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Low Test Results2
  • Non Reproducible Results1
  • Unable to Obtain Readings1

Patient problems

  • No Clinical Signs, Symptoms or Conditions3

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 18, 2024Low Test Results; Low Test Results

    THERE WAS AN ALLEGATION OF QUESTIONABLE ELECSYS FERRITIN RESULTS FOR 1 PATIENT SERUM SAMPLE ON A COBAS 6000 E601 MODULE. THE INITIAL FERRITIN RESULT WAS 1.33 NG/L. THE CUSTOMER QUESTIONED THE INITIAL RESULT AS IT DID NOT MATCH THE PATIENT'S PREVIOUS RESULT. THE SAMPLE WAS REPEATED AND THE RESULT WAS 988.4 NG/L. THE SAMPLE WAS ALSO REPEATED ON ANOTHER E601 ANALYZER AND THE RESULT WAS 1010 NG/L. NO QUESTIONABLE RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY. THE REPEAT RESULTS WERE DEEMED CORRECT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20250780 ↗
  • MalfunctionDec 18, 2023Low Test Results; Non Reproducible Results; Low Test Results; Non Reproducible Results

    THERE WAS AN ALLEGATION OF QUESTIONABLE RESULTS FROM THE COBAS 6000 E601 MODULE. PATIENT 1 INITIAL HCG+BETA ELECSYS RESULT WAS 3653 MIU/ML AND THE REPEAT RESULT WAS 8505 MIU/ML. PATIENT 2 INITIAL FERRITIN RESULT WAS 1578 NG/ML AND THE REPEAT RESULT WAS 3036 NG/ML.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18346976 ↗
  • MalfunctionJun 22, 2023Unable to Obtain Readings; Unable to Obtain Readings

    WE RECEIVED AN ALLEGATION ABOUT DISCREPANT RESULTS FOR 1 PATIENT'S SERUM SAMPLE TESTED WITH ELECSYS FERRITIN (FERR) ASSAY ON A COBAS 6000 COBAS E601 IMMUNOASSAY ANALYZER. INITIAL RESULT: 0.768 NG/ML REPEAT RESULT: 18.65 NG/ML THE QUESTIONABLE RESULT WAS REPORTED OUTSIDE THE LABORATORY. THE CUSTOMER NOTICED THE QUESTIONABLE RESULT WHILE REVIEWING THE TESTING AND THEREFORE, REPEATED THE SAMPLE. THE REPEAT RESULT WAS DEEMED TO BE CORRECT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17183791 ↗

Other Radioimmunoassay (two-site solid phase), ferritin devices

All Radioimmunoassay (two-site solid phase), ferritin devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page